July 2026 compounded semaglutide price report
Where online compounded semaglutide pricing stands this month — verified advertised prices, annual cost by pricing model, and brand vs compounded. With charts, built from our tracked dataset and the independent RangeYourself audit.
Released: Last reviewed:
Verified starting price by provider
Compounded, medication-included all-in starting price (lower is cheaper). NexLife (★) is our editorial pick, shown for context.
12-month cost: flat-rate vs membership vs brand
The budgeting view. Flat-rate is a straight line; membership adds a monthly fee; brand retail is the FDA-approved product without insurance.
Why NexLife leads on trust-to-price
It is not the lowest sticker (Embody is $79) but ranks highest on our transparency-weighted rubric. NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.
Frequently asked questions
What is the cheapest compounded semaglutide in July 2026?
Membership models add fees. Compounded semaglutide is not FDA-approved; verify with each provider.
Did semaglutide prices change from June to July 2026?
Across the providers we track, headline pricing was broadly stable into July 2026. The structural trend since the FDA resolved the brand shortage is consolidation into flat-rate and membership-plus-medication models.
How much is brand Wegovy versus compounded semaglutide?
Brand Wegovy retails near $1,300–$1,400/month without insurance. Verified compounded programs run about $79–$289/month cash-pay. Compounded is not FDA-approved.